<DOC>
	<DOCNO>NCT02832258</DOCNO>
	<brief_summary>Urinary tract infection due Extended-spectrum beta-lactamase produce enterobacteriaceae ( E-ESBL UTI ) become frequent problem . A large variety prescription antibiotic E-ESBL UTI child absolute recommendation regard optimal treatment E-ESBL nearly impossible time . Our aim describe characteristic treatment urinary tract infection cause Extended spectrum betalactamase-producing Enterobacteriaceae child .</brief_summary>
	<brief_title>Urinary Tract Infection Due Beta-lactamase-producing Enterobacteriaceae Children</brief_title>
	<detailed_description>In prospective observational study March 2013 March 2017 , child ( 0 18 year ) ESBL-E UTI enrol 24 pediatric department France . Clinical biological characteristic , risk factor infection E-ESBL , first second line antibiotic therapy analyze . The investigator use Kaplan-Meier method estimate time fever defervescence hospitalization duration , Log-rank test ass equality survivor function . The investigator also analyze resistance pattern molecular characterization ESBL type isolates .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<criteria>All inpatient outpatient 18 year UTI ( cystitis febrile UTI ) Clinical sign associate positive EESBL urine culture dependent urine collection method previously describe ( Stein R , EAU/ESPU guideline ) antibiotic treatment target strain . Refusal participate study Children mixed microbial strain repeat infection exclude</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Enterobacteria</keyword>
	<keyword>Children</keyword>
	<keyword>Febrile urinary tract infection</keyword>
	<keyword>Cystitis</keyword>
	<keyword>Extended-spectrum beta-lactamase-producing Enterobacteriaceae</keyword>
</DOC>